Verition Fund Management
LXRX icon

Verition Fund Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Verition Fund Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-18,158
Closed -$30.5K – 3390
2024
Q2 		$30.5K Buy
+18,158
New +$32.6K ﹤0.01% 2839
2023
Q4 		– Sell
-91,700
Closed -$100K – 2539
2023
Q3 		$100K Buy
91,700
+18,400
+25% +$32.3K ﹤0.01% 2120
2023
Q2 		$168K Buy
+73,300
New +$195K ﹤0.01% 1897
2014
Q1 		– Sell
-1,844
Closed -$23K – 584
2013
Q4 		$23K Buy
+1,844
New +$29.3K ﹤0.01% 489

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Verition Fund Management's LXRX Position: Q3 2024 in Review

Verition Fund Management sold out of Lexicon Pharmaceuticals (LXRX) in Q3 2024, closing a stake of 18,158 shares — an estimated $30.5K sold.

Verition Fund Management first reported a position in LXRX in Q4 2013 and held it in 4 quarters. The position peaked at $168K in Q2 2023. 137 funds tracked by Wall St. Rank hold LXRX as of Q3 2024.

  • Verition Fund Management reported no remaining Lexicon Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Verition Fund Management sold 18,158 Lexicon Pharmaceuticals shares in Q3 2024, an estimated $30.5K.
  • Verition Fund Management first reported a position in Lexicon Pharmaceuticals in Q4 2013 and held it in 4 quarters.
  • Verition Fund Management's Lexicon Pharmaceuticals position peaked at $168K in Q2 2023.
  • 137 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2024.

Based on Verition Fund Management's 13F filing for Q3 2024, filed 14 Nov 2024.